While AID and manual insulin delivery systems have reached their peak in terms of performance, the inclusion of clinically relevant analytes and detection techniques could markedly improve diabetes management, as well as reduce T1D‐related complications. This evidence concerns the gene INS and type 1 diabetes mellitus.